Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Curr Oncol Rep ; 22(7): 65, 2020 06 08.
Article in English | MEDLINE | ID: mdl-32514647

ABSTRACT

PURPOSE OF REVIEW: The review aims to summarize the present knowledge about cardiovascular toxicities associated with immune checkpoint inhibitors (ICI) and dissect underlying mechanism associated with individual cardiovascular toxicity. RECENT FINDINGS: Widespread use of ICI therapy has allowed for increasing recognition of a wide spectrum of immune-related adverse events that leave all organ systems vulnerable. Immune-mediated cardiovascular toxicities, initially thought to be rare, are more often being reported and present considerable challenges due to their non-specific clinical presentation, potential to have a fulminant progression, and overlap with other cardiovascular and general medical illnesses. Myocarditis is the most common manifestation of ICI-associated cardiovascular toxicity. Pericardial diseases, vasculitis, Takotsubo syndrome, conduction abnormalities, and destabilization of atherosclerotic lesions constitute other significant adverse events. At this stage, mechanisms underlying fundamental biology of cardiac toxicity have not been studied comprehensively and there remain gaps of knowledge in the current literature concerning the underlying pathomechanisms. It is hypothesized that immune-mediated myocarditis is a result of an exaggerated adaptive immune response against shared epitopes in the myocardium and tumor cells. Further, underlying mechanism of other cardiovascular toxicities is still unclear, further compounded by sparsity of epidemiological data. It is paramount to understand the mechanisms behind ICI-induced cardiovascular toxicities to develop appropriate treatment and prevention strategies and minimize the morbidity and mortality of cancer patients undergoing ICI therapy.


Subject(s)
Cardiovascular Diseases/chemically induced , Immune Checkpoint Inhibitors/adverse effects , Acute Coronary Syndrome/chemically induced , Arrhythmias, Cardiac/chemically induced , Cardiotoxicity/drug therapy , Humans , Myocarditis/chemically induced , Takotsubo Cardiomyopathy/chemically induced
2.
Perit Dial Int ; 39(3): 289-291, 2019.
Article in English | MEDLINE | ID: mdl-31088934

ABSTRACT

We herewith report 2 unusual cases of spontaneous peritoneal dialysis (PD) catheter fracture in intramural and intra-abdominal segments, respectively, in PD patients with long vintage. There were no associated infections or mechanical trauma. The patients presented with PD catheter outflow failure. Both the patients had their catheter replaced and resumed PD without any further issues. Probable causes and comparison with the reported cases are discussed.


Subject(s)
Catheters, Indwelling/adverse effects , Device Removal/methods , Equipment Failure , Kidney Failure, Chronic/therapy , Peritoneal Dialysis, Continuous Ambulatory/adverse effects , Abdominal Cavity/growth & development , Abdominal Cavity/surgery , Equipment Design , Female , Follow-Up Studies , Humans , Kidney Failure, Chronic/diagnosis , Long-Term Care , Middle Aged , Peritoneal Dialysis, Continuous Ambulatory/instrumentation , Risk Assessment
SELECTION OF CITATIONS
SEARCH DETAIL
...